Insider Trading April 16, 2026 05:04 PM

TransDigm Co-COO Disposes $4.99M of Shares, Exercises Options in Same Session

Joel Reiss sold 3,250 TransDigm shares and exercised options to buy 3,900 shares as the company advances acquisitions and new debt issuances

By Avery Klein TDG
TransDigm Co-COO Disposes $4.99M of Shares, Exercises Options in Same Session
TDG

Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC (NYSE: TDG), sold 3,250 shares on April 15, 2026, realizing about $4.99 million, and concurrently exercised options to acquire 3,900 shares. The transactions come as TransDigm reports preliminary quarterly results, closes recent acquisitions, and prices new debt to fund further deals and repurchases.

Key Points

  • Joel Reiss sold 3,250 TransDigm shares on April 15, 2026, for roughly $4.99 million and exercised options to buy 3,900 shares at $284.97 the same day.
  • TransDigm reported preliminary thirteen-week results with estimated net sales of $2.54 billion to $2.545 billion and EBITDA As Defined of $1.33 billion to $1.335 billion; figures remain subject to final adjustments.
  • The company completed acquisitions totaling about $2.2 billion and has priced new debt offerings - $2 billion including $1.2 billion of 6.125% Senior Subordinated Notes due 2034, plus a $1.5 billion debt pricing tied to the Stellant Systems acquisition and $800 million in share repurchases.

Joel Reiss, who serves as Co-Chief Operating Officer at TransDigm Group INC (NYSE: TDG), executed a sale of 3,250 shares of common stock on April 15, 2026, generating approximately $4.99 million in proceeds. The shares were disposed of at prices spanning $1274.5734 to $1294.772.

The stock is trading at $1,228.23 at present, which corresponds to a market capitalization for the aerospace components manufacturer of $69.52 billion.

On the same trading day, Reiss also exercised stock options to acquire 3,900 shares of TransDigm Group at an exercise price of $284.97 per share, for a cumulative exercise value of $1111383.

After completing the sale and the option exercise, Reiss holds 3,760 shares of TransDigm Group INC directly.

Independent analysis from InvestingPro included in public reporting indicates that TransDigm appears undervalued relative to its Fair Value assessment. The company is trading at a price-to-earnings ratio of 39.64 and reports gross profit margins of nearly 60%. The InvestingPro disclosure notes that an additional 12 InvestingPro Tips are available for those seeking more granular commentary on TDG's valuation and operating performance.


Beyond insider activity, TransDigm has been active on multiple financial and strategic fronts. The company released preliminary results for the thirteen-week period ending March 28, 2026, estimating net sales between $2.54 billion and $2.545 billion, with EBITDA As Defined in a range from $1.33 billion to $1.335 billion. These figures were identified as preliminary and subject to final adjustments.

On the corporate development side, TransDigm completed acquisitions of Jet Parts Engineering and Victor Sierra Aviation Holdings for a combined consideration of approximately $2.2 billion. The company financed those transactions using cash on hand along with proceeds from earlier debt offerings.

To support these deals and other capital needs, TransDigm has also priced $2 billion in new debt, which includes $1.2 billion of 6.125% Senior Subordinated Notes due 2034. Separately, the company announced the pricing of $1.5 billion in debt intended to finance the acquisition of Stellant Systems, Inc., and to fund $800 million in share repurchases.

In the context of equity research coverage, Truist has retained a Buy rating on TransDigm, while flagging that rising oil prices could exert pressure on aerospace aftermarket stocks and potentially influence demand for parts.


These developments - the insider transactions, the preliminary quarter results, the recent acquisitions, and the debt transactions - underscore TransDigm's ongoing acquisition-driven growth strategy and the attendant capital planning required to execute it. The company is balancing near-term financing activity with shareholder actions including planned repurchases, while analysts point to valuation metrics and margin strength in their assessments.

Risks

  • Rising oil prices, as noted by Truist, could pressure aerospace aftermarket demand and thus affect parts demand - impacting the aerospace and defense supply chain sector.
  • Preliminary financial results are subject to final adjustments, introducing uncertainty to near-term earnings and sales metrics - relevant to equity investors and market analysts.
  • Increased debt issuance to fund acquisitions and repurchases raises leverage and capital structure risk for TransDigm, affecting credit markets and fixed-income investors.

More from Insider Trading

OrbiMed Expands Stake in Traws Pharma via Strategic Private Placement Apr 28, 2026 Rexford Industrial Realty General Counsel Completes $1.18 Million Stock Sale Apr 28, 2026 Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises Apr 28, 2026 Abbott Laboratories Director Daniel Starks Executes Substantial Open Market Share Purchase Apr 28, 2026 BlackRock President Robert Kapito Executes $9.2 Million Share Sale Apr 28, 2026